Clinical trials are progressing quickly, but many still stall before the first patient joins. Even with strong patient interest and additional funding, delays often begin during screening. Complex rules, insufficient staff, and inconsistent processes keep qualified participants from moving forward.
When screening is ineffective, trials have more people who don't qualify, longer recruitment times, and greater stress on the team. Every delay adds cost, risks data quality, and erodes patients' trust in the process. What seems like a small issue often escalates into a larger problem for the entire study.
Precision screening means identifying patients early, applying clear rules, following a structured process, and ensuring they understand what's happening. When screening is configured to handle higher volumes, teams can identify the right patients faster while adhering to rules and maintaining accurate data.
Outsourcing provides access to teams that focus solely on screening, use standardised processes, and stay involved throughout, allowing internal trial teams to focus on leading the study and the most important tasks.
As trials become more complex, precision screening will be key to readiness and success. Teams that build scalable screening processes will move faster, enrol patients more easily, and achieve better results.
To learn how precision screening helps with enrolment and improves patient experience, download our white paper "The Future of Clinical Trials: Precision Screening for Better Patient Outcomes," or contact Select VoiceCom to see how outsourced screening support in the Philippines can help your trials move forward.